Bessemer Group Inc. Lowers Stock Position in Cencora, Inc. $COR

Bessemer Group Inc. trimmed its holdings in Cencora, Inc. (NYSE:COR) by 11.0% during the first quarter, HoldingsChannel.com reports. The fund owned 1,215,006 shares of the company’s stock after selling 150,050 shares during the period. Bessemer Group Inc.’s holdings in Cencora were worth $381,682,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of COR. Nordea Investment Management AB increased its position in Cencora by 3.8% in the 4th quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock valued at $426,715,000 after acquiring an additional 45,712 shares during the period. Groupama Asset Managment acquired a new stake in Cencora during the 3rd quarter worth approximately $1,225,000. Assetmark Inc. lifted its position in Cencora by 57.0% during the 4th quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock worth $22,724,000 after acquiring an additional 24,431 shares during the period. ExodusPoint Capital Management LP purchased a new position in shares of Cencora in the 4th quarter valued at approximately $16,487,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Cencora by 162.4% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 289,370 shares of the company’s stock valued at $97,735,000 after purchasing an additional 179,086 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Cencora Stock Performance

Shares of COR stock opened at $307.80 on Friday. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The stock has a 50 day simple moving average of $279.05 and a 200-day simple moving average of $317.75. The company has a market cap of $59.88 billion, a price-to-earnings ratio of 23.60, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter last year, the firm earned $4.42 earnings per share. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts forecast that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora declared that its Board of Directors has authorized a stock repurchase program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 3.9% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.

Cencora Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s payout ratio is presently 18.40%.

Insider Activity at Cencora

In related news, Director Lauren M. Tyler purchased 550 shares of the stock in a transaction dated Monday, June 22nd. The shares were acquired at an average cost of $270.23 per share, with a total value of $148,626.50. Following the purchase, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. This trade represents a 14.44% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.38% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on COR. Morgan Stanley set a $342.00 target price on Cencora in a report on Friday, May 8th. Bank of America lifted their price objective on shares of Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Citigroup dropped their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Weiss Ratings downgraded shares of Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 30th. Finally, Barclays reduced their target price on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research note on Wednesday, June 10th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $367.75.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.